Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wouters

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Arthritis Care & Research|March 2, 2010
Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritisH M Albers, D M C Brinkman, S S M Kamphuis, et al.
Arthritis and Rheumatism|January 1, 2009
Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritisH M Albers, J A M Wessels, R J H M van der Straaten, et al.
Heart Rhythm|June 7, 2026
Prognostic value of the baseline CAVIAR response score after cardiac resynchronization therapy: ten-year outcomes from the Markers and Response to CRT (MARC) studyWillem Gerrits, Cheyenne S L Chiu, Leonie Smit, et al.
Trials|December 10, 2020
A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico studyT Vanassche, M M Engelen, Q Van Thillo, et al.
Trials|December 30, 2020
Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico studyT Vanassche, M M Engelen, Q Van Thillo, et al.
Arthritis and Rheumatism|February 28, 2009
Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritisH M Albers, F A S Kurreeman, G Stoeken-Rijsbergen, et al.
The International Journal of Cardiovascular Imaging|February 13, 2026
Left atrioventricular coupling index in patients undergoing cardiac resynchronization therapyCheyenne S L Chiu, Willem Gerrits, Sophie C Rier, et al.
Annals of the Rheumatic Diseases|December 19, 2013
Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritisH M Albers, T H C M Reinards, D M C Brinkman, et al.
Annals of the Rheumatic Diseases|July 25, 2014
CD226 (DNAM-1) is associated with susceptibility to juvenile idiopathic arthritisT H C M Reinards, H M Albers, D M C Brinkman, et al.
Nature Communications|July 6, 2021
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severityL Vanderbeke, P Van Mol, Y Van Herck, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Arthritis Care & Research|March 2, 2010
Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritisH M Albers, D M C Brinkman, S S M Kamphuis, et al.
Arthritis and Rheumatism|January 1, 2009
Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritisH M Albers, J A M Wessels, R J H M van der Straaten, et al.
Heart Rhythm|June 7, 2026
Prognostic value of the baseline CAVIAR response score after cardiac resynchronization therapy: ten-year outcomes from the Markers and Response to CRT (MARC) studyWillem Gerrits, Cheyenne S L Chiu, Leonie Smit, et al.
Trials|December 10, 2020
A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico studyT Vanassche, M M Engelen, Q Van Thillo, et al.
Trials|December 30, 2020
Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico studyT Vanassche, M M Engelen, Q Van Thillo, et al.
Arthritis and Rheumatism|February 28, 2009
Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritisH M Albers, F A S Kurreeman, G Stoeken-Rijsbergen, et al.
The International Journal of Cardiovascular Imaging|February 13, 2026
Left atrioventricular coupling index in patients undergoing cardiac resynchronization therapyCheyenne S L Chiu, Willem Gerrits, Sophie C Rier, et al.
Annals of the Rheumatic Diseases|December 19, 2013
Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritisH M Albers, T H C M Reinards, D M C Brinkman, et al.
Annals of the Rheumatic Diseases|July 25, 2014
CD226 (DNAM-1) is associated with susceptibility to juvenile idiopathic arthritisT H C M Reinards, H M Albers, D M C Brinkman, et al.
Nature Communications|July 6, 2021
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severityL Vanderbeke, P Van Mol, Y Van Herck, et al.
Pageof 8